Gilead Sciences and Kite Pharma Announce Layoffs, Closure of Seattle and Philadelphia Offices

Layoffs and Office Closures:
Gilead Sciences and its subsidiary Kite Pharma are laying off employees and closing their offices in Seattle and Philadelphia. The Seattle office will lay off 72 employees effective January 17, 202534.

Reason for Layoffs:
The layoffs are part of a strategic effort to align resources with long-term strategic goals, including relocating some teams and preparing for potential new product launches4.

Impact on Employees:
Employees whose roles are eliminated can apply for other positions within the company4.

Product Launches:
Gilead is preparing for six potential new launches by the end of 2030, starting with lenacapavir for HIV prevention in 20254.

Financial Context:
Gilead recently reported a 7% increase in third-quarter product sales to $7.5 billion year over year, but cell therapy product sales were relatively flat4.

Kite Pharma’s Impact:
Kite Pharma will close its Philadelphia facility, and its workforce has previously experienced layoffs about a year ago4.

Sources:

3. https://www.fiercebiotech.com/biotech/gilead-lays-72-seattle-workers-plans-shutter-rd-support-site

4. https://www.biospace.com/job-trends/gilead-and-kite-are-cutting-employees-closing-seattle-philadelphia-sites